• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Acentra Health Welcomes Distinguished Public Sector Health Leaders Calder Lynch and Jami Snyder to its Healthcare Advisory Board; Appoints Julie Boughn as New Chair

    2/4/25 9:58:04 AM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email

    MCLEAN, Va., Feb. 04, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today announced the appointment of Calder Lynch and Jami Snyder to its healthcare advisory board. With decades of experience leading state and federal government healthcare programs, the subject matter experts will advise the company and its clients on healthcare policies and trends as well as strategies to improve health outcomes at a lower cost.

    "We are excited to welcome Calder Lynch and Jami Snyder to Acentra Health's Healthcare Advisory Board," said Todd Stottlemyer, CEO of Acentra Health. "Each brings decades of experience navigating and improving complex healthcare delivery systems across state and federal governments to successfully drive better outcomes in patient care. Their guidance will enhance our strategy to help our clients address their toughest challenges and deliver better health outcomes for the populations they serve."

    About Calder Lynch

    Calder Lynch is a nationally recognized healthcare executive with extensive experience leading transformative change in Medicaid and healthcare services. He brings expertise in strategy, public policy, and healthcare innovation. Lynch previously served as acting deputy administrator and chief of staff at the Centers for Medicare & Medicaid Services (CMS), as well as deputy administrator and director of the Center for Medicaid & CHIP (Children's Health Insurance Program) Services during President Trump's first term in office. While at CMS, Lynch led the early Medicaid COVID-19 response, rapidly deploying new policies and processes that enabled over 500 approvals of emergency actions aimed at supporting state efforts to increase telehealth access, streamline eligibility processes, and sustain community-based long-term-care providers. Prior to his federal service, Lynch held leadership roles as Medicaid director for Nebraska, as chief of staff for the Louisiana Department of Health and Hospitals, and as senior vice president at Commonwealth Care Alliance. He currently serves as vice president and regional Medicaid president for Humana in its Texas division.

    "I am pleased to join Acentra Health's Healthcare Advisory Board and collaborate with such a distinguished group of experts," said Lynch. "The company's mission aligns with my own passion for using emerging advances in technology to improve quality of care and efficiency in healthcare operations, and I look forward to helping Acentra Health address its clients' most complex challenges."

    About Jami Snyder

    Jami Snyder is a seasoned healthcare leader with more than 20 years of experience in public health and the private healthcare industry. Her expertise spans regulatory oversight, policy development, and leadership advisory services to states, payers, and providers. Snyder was appointed by Arizona Governor Doug Ducey to serve as the state's Medicaid director, holding that position for four years, where she led transformative initiatives to improve access and quality of care, particularly during the COVID-19 pandemic. Previously, Snyder served as associate commissioner for Medicaid/CHIP (Medicaid director) in Texas. She also served as president of the board for the National Association of Medicaid Directors (NAMD) and is a commissioner for the Medicaid and CHIP Payment and Access Commission (MACPAC), a non-partisan committee that advises Congress and state governments on policy and access issues related to Medicaid and CHIP. Snyder is currently president and CEO of JSN Strategies, LLC, a healthcare consultancy firm.

    "Acentra Health has a respected reputation as a trusted partner to state and federal clients for driving meaningful change that improves healthcare outcomes and delivers program value," said Snyder. "I look forward to contributing to the company's efforts to improve the quality and efficiency of healthcare delivery for healthcare consumers across the country."

    An additional change to the board includes the appointment of current board advisor Julie Boughn as chair. A former director of the Data and Systems Group for CMS's Center for Medicaid and CHIP Services (CMCS), Boughn joined the board in 2022 following an esteemed 30-year career in the health and information technology sectors. She specializes in data analysis, strategy, and Medicaid enterprise system modernization.

    In addition to advising Acentra Health's executive leaders, healthcare advisory board members serve as a vital resource to the company's portfolio of state, federal, and commercial clients. Members participate in regularly scheduled client focus group meetings, providing strategies for improving healthcare delivery and maximizing budget dollars. Advisory board members also support the company and its clients as subject matter experts, presenting at industry events and conferences. The nine-member board comprises experts across government, healthcare, and technology, including:

    • Dr. Raquel Bono – Retired Vice Admiral, U.S., Navy and former Director, Defense Health Agency.
    • Julie Boughn – Former Director, Data and Systems Group at the Center for Medicaid and CHIP Services within CMS, and healthcare technology innovator.
    • Aneesh Chopra – Chief Strategy Officer, Arcadia, and the nation's first U.S. Chief Technology Officer under President Obama.
    • Bobbie Greene Kilberg – Former President and CEO, Northern Virginia Technology Council, and technology policy expert.
    • Dr. Elder Granger – Retired Major General, U.S. Army, former Deputy Director/Program Executive Officer, TRICARE Management Activity, and President and CEO, THE 5Ps LLC, focusing on healthcare leadership.
    • Ryan Howells – Principal at Leavitt Partners and leading expert in healthcare data interoperability at the CARIN Alliance.
    • Charlies Milligan – CEO at Health Management Associates and former Medicaid Director for Maryland and New Mexico, with extensive policy and programmatic expertise.

    Read their bios and learn more acentra.com.

    About Acentra Health

    Acentra Health combines public sector knowledge, clinical expertise, and technological ingenuity to modernize the healthcare experience for state, federal, and commercial partners, and their priority populations. From designing and developing advanced claims, encounter, and provider solutions that drive efficiency and cost savings to delivering clinically focused service models for care management, clinical assessments, and quality oversight, Acentra Health is accelerating better health outcomes. Acentra Health is backed by Carlyle (NASDAQ:CG), a global investment firm. Learn more at acentra.com.

    Media Contact:

    Janice Moore

    Vice President, Corporate Communications

    703-214-3552

    Photos accompanying this announcement are available at: 

    https://www.globenewswire.com/NewsRoom/AttachmentNg/218de5be-f33a-48e4-92da-7b696ac3bea8

    https://www.globenewswire.com/NewsRoom/AttachmentNg/60097542-70e4-4621-a0fb-b76671d2027e

    https://www.globenewswire.com/NewsRoom/AttachmentNg/7c0f41f0-1e82-41b1-9565-8f06173c152e



    Primary Logo

    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    2/24/2026$67.00Outperform
    RBC Capital Mkts
    12/11/2025$74.00Buy
    UBS
    10/3/2025$74.00Outperform
    BMO Capital Markets
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    More analyst ratings

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    JLL secures $370M refinancing for Society Brooklyn in Gowanus

    Brookfield funds bridge loan for 517-unit waterfront propertyNEW YORK, March 17, 2026 /PRNewswire/ -- JLL's Capital Markets group announced today that it has arranged a $370 million refinancing for Society Brooklyn, a premier 517-unit, two-tower residential development positioned along the Gowanus Canal in Brooklyn's Gowanus neighborhood.JLL worked on behalf of the borrowers, Property Markets Group and The Carlyle Group, to secure the three-year bridge loan from Brookfield Asset Management.Society Brooklyn features two complementary towers spanning 455,666 square feet of rentable space across 517 units, including 385 market-rate and 132 affordable apartments. The development also includes 57

    3/17/26 4:23:00 PM ET
    $BAM
    $CG
    $JLL
    Other Consumer Services
    Consumer Discretionary
    Investment Managers
    Finance

    Carlyle Presents Growth Outlook at 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) is announcing its growth outlook and financial objectives at the 2026 Shareholder Update, beginning today at 8:30 a.m. EST. The program will include presentations by senior leadership, followed by a Q&A session. Carlyle will announce three-year financial targets to be achieved by the end of 2028, including: FRE of $1.9+ billionInflows of $200+ billionDE per common share of $6.00+ Carlyle is also announcing that its Board of Directors has approved a new $2 billion share repurchase authorization. The authorization provides the firm with flexibility to repurchase shares as part of its disc

    2/26/26 7:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Sumitomo Heavy Industries and ARMADA's IMIA Formalize Strategic Alliance to Support U.S. Navy Readiness in Japan

    Signing at Sumitomo Heavy Industries headquarters marks the launch of a long-term partnership focused on operational readiness and mission-critical ship maintenance. Sumitomo Heavy Industries, Ltd. (SHI) and IMIA, an operating company of ARMADA, today announced the signing of their Alliance Agreement, launching a strategic partnership to support U.S. Navy operations in Japan and surrounding regions. The in-person signing ceremony was held at Sumitomo Heavy Industries' headquarters building, Sumitomo Kaikan, in Tokyo. The alliance brings together SHI's long-established industrial presence and execution capabilities that have supported the U.S. Navy 7th Fleet in Japan for decades with IMI

    2/25/26 1:10:00 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Carlyle Group with a new price target

    RBC Capital Mkts initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $67.00

    2/24/26 7:47:48 AM ET
    $CG
    Investment Managers
    Finance

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Large owner Carlyle Group Inc. sold $1,070,339,440 worth of shares (26,105,840 units at $41.00) and disposed of 2,113,483 shares (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    3/12/26 4:30:20 PM ET
    $CG
    Investment Managers
    Finance

    Large owner Carlyle Group Inc. converted options into 9,297,883 shares and disposed of 9,297,883 units of Class B Common Stock (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    3/6/26 7:02:25 PM ET
    $CG
    Investment Managers
    Finance

    Co-President Redett John C. was granted 9,114 shares, increasing direct ownership by 0.49% to 1,857,426 units (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    2/20/26 6:49:52 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    SEC Filings

    View All

    SEC Form 10-K filed by The Carlyle Group Inc.

    10-K - Carlyle Group Inc. (0001527166) (Filer)

    2/27/26 4:13:57 PM ET
    $CG
    Investment Managers
    Finance

    The Carlyle Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    2/26/26 7:00:39 AM ET
    $CG
    Investment Managers
    Finance

    SEC Form 13F-HR filed by The Carlyle Group Inc.

    13F-HR - Carlyle Group Inc. (0001527166) (Filer)

    2/13/26 4:31:59 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Financials

    Live finance-specific insights

    View All

    Carlyle Presents Growth Outlook at 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) is announcing its growth outlook and financial objectives at the 2026 Shareholder Update, beginning today at 8:30 a.m. EST. The program will include presentations by senior leadership, followed by a Q&A session. Carlyle will announce three-year financial targets to be achieved by the end of 2028, including: FRE of $1.9+ billionInflows of $200+ billionDE per common share of $6.00+ Carlyle is also announcing that its Board of Directors has approved a new $2 billion share repurchase authorization. The authorization provides the firm with flexibility to repurchase shares as part of its disc

    2/26/26 7:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Secured Lending, Inc. Announces Financial Results For Fourth Quarter and Full Year Ended December 31, 2025, Declares First Quarter 2026 Dividend of $0.40 Per Common Share

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its fourth quarter and full year ended December 31, 2025. Alex Chi, CGBD's Chief Executive Officer, said, "As CGBD's newly appointed CEO, I look forward to continuing to build on Carlyle's strong track record and world-class platform. Building off record origination volume in the fourth quarter and full year 2025, we continue to expand our origination apparatus and are focused on further harnessing the full power of the OneCarlyle platform. The depth of our underwriting se

    2/24/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    Carlyle Secured Lending, Inc. Schedules Earnings Release and Quarterly Earnings Call to Discuss its Financial Results for the Fourth Quarter and Full Year Ended December 31, 2025

    NEW YORK, Jan. 27, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. ("Carlyle Secured Lending") (NASDAQ:CGBD) will host a conference call at 11:00 a.m. (Eastern Time) on Wednesday, February 25, 2026 to announce its financial results for the fourth quarter and full year ended December 31, 2025. The Company will report its quarterly financial results on Tuesday, February 24, 2026. The conference call will be available via public webcast via a link on Carlyle Secured Lending's website at carlylesecuredlending.com and will also be available on the website soon after the call's completion. About Carlyle Secured Lending, Inc.     Carlyle Secured Lending, Inc. is a publicly traded (NASDA

    1/27/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    Carlyle to Host 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company's senior leadership team and will review Carlyle's growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any

    2/2/26 8:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Balajee Sethuraman as Executive Vice President and Chief Business Services Officer

    MCLEAN, Va., Jan. 27, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Balajee Sethuraman as Executive Vice President and Chief Business Services Officer (CBSO), where he will lead the company's business services and delivery operations. This strategic addition to Acentra Health's executive leadership team supports its ongoing efforts to streamline and strengthen enterprise-wide delivery through a unified operating model. "Balajee is a transformative leader with exceptional experience scaling global team

    1/27/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Appoints Deborah Ricci as Executive Vice President and Chief Financial Officer

    MCLEAN, Va., Jan. 14, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced the appointment of Deborah Ricci as Executive Vice President and Chief Financial Officer (CFO). Ricci joins Acentra Health from Guidehouse Inc., where she most recently served as Partner and Chief Financial & Administrative Officer. In that role, she oversaw finance and accounting functions as well as quality, risk, security, and facilities, while supporting the firm's continued growth and operational transformation. Earlier in her career, Ricci held mu

    1/14/26 9:35:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance